Programming gene and engineered-cell therapies with synthetic biology

Programming gene and engineered-cell therapies with synthetic biology

Gene and engineered-cell therapies promise to treat diseases by genetically modifying cells to carry out therapeutic tasks. Although the field has had some success in treating monogenic disorders and hematological malignancies, current approaches are limited to overexpression of one or a few transge...

Full description

Bibliographic Details
Main Authors: Kitada, Tasuku, DiAndreth, Breanna, Teague, Brian Paul, Weiss, Ron
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering
Format: Article
Language:en_US
Published: American Association for the Advancement of Science (AAAS) 2018
Online Access:http://hdl.handle.net/1721.1/118768
https://orcid.org/0000-0003-2265-3363
https://orcid.org/0000-0002-0302-6834
https://orcid.org/0000-0002-9833-2817
https://orcid.org/0000-0003-0396-2443

Internet

http://hdl.handle.net/1721.1/118768
https://orcid.org/0000-0003-2265-3363
https://orcid.org/0000-0002-0302-6834
https://orcid.org/0000-0002-9833-2817
https://orcid.org/0000-0003-0396-2443

Similar Items